Rilpivirine

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1778 publications

Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature.

Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature.

Journal: International journal of STD & AIDS
Published: June 17, 2026

A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.

A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.

Journal: Antimicrobial agents and chemotherapy
Published: June 10, 2026

Injectable long-acting pre-exposure prophylaxis for HIV prevention: advancements and future directions in pharmacotherapy.

Injectable long-acting pre-exposure prophylaxis for HIV prevention: advancements and future directions in pharmacotherapy.

Journal: Expert opinion on pharmacotherapy
Published: June 04, 2026

Characteristics Associated with HIV Pre-Exposure Prophylaxis Persistence Among Men Who Have Sex with Men in the United States: Results from the American Men's Internet Survey, 2023-2024.

Characteristics Associated with HIV Pre-Exposure Prophylaxis Persistence Among Men Who Have Sex with Men in the United States: Results from the American Men's Internet Survey, 2023-2024.

Journal: AIDS patient care and STDs
Published: May 27, 2026

Epidemiological impact of prioritising long-acting injectable cabotegravir to MSM with low PrEP use adherence in the Netherlands: A mathematical modelling study.

Epidemiological impact of prioritising long-acting injectable cabotegravir to MSM with low PrEP use adherence in the Netherlands: A mathematical modelling study.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: May 25, 2026

Feasibility and Implementation Considerations for Long-Acting Antiretroviral Therapy in Pakistan: A Qualitative Study of Healthcare Providers and Programmatic Stakeholders.

Feasibility and Implementation Considerations for Long-Acting Antiretroviral Therapy in Pakistan: A Qualitative Study of Healthcare Providers and Programmatic Stakeholders.

Journal: Journal of the International Association of Providers of AIDS Care
Published: May 19, 2026

Long-acting injectable cabotegravir HIV PrEP uptake, adherence, and persistence in two large US integrated healthcare systems.

Long-acting injectable cabotegravir HIV PrEP uptake, adherence, and persistence in two large US integrated healthcare systems.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: May 18, 2026

Integrase Inhibitors: Redefining HIV-1 Treatment and Future Challenges.

Integrase Inhibitors: Redefining HIV-1 Treatment and Future Challenges.

Journal: Missouri medicine
Published: May 13, 2026

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Journal: Antiviral therapy
Published: May 13, 2026

CROI 2026: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases.

CROI 2026: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases.

Journal: Topics in antiviral medicine
Published: May 13, 2026

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply.

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply.

Journal: The New England journal of medicine
Published: May 13, 2026

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.

Journal: The New England journal of medicine
Published: May 13, 2026
Showing 1-12 of 1,778

Last Updated: 06/30/2026